New process for the production of melagatran

Details for Australian Patent Application No. 2004249658 (hide)

Owner AstraZeneca AB

Inventors Sjogren, Magnus; Musil, Tibor; Grehn, Marcus

Agent Davies Collison Cave

Pub. Number AU-B-2004249658

PCT Pub. Number WO2004/113364

Priority 0301879-3 25.06.03 SE

Filing date 23 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 1 February 2007

International Classifications

C07K 5/065 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/113364 Priority application(s): WO2004/113364

1 February 2007 Application Accepted

  Published as AU-B-2004249658

31 May 2007 Standard Patent Sealed

21 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249661-Fastener having improved penetration capability

2004249655-Novel imidazopyridine compound ii with therapeutic effect